In 2024, Torrent Pharmaceuticals conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards. The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
Metric (tonnes) | 2024 | 2023 | 2022 | 2021 - 2017 |
---|---|---|---|---|
Total Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Waste Recovered | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Total Hazardous Waste Generated | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
Non-Hazardous Waste Disposed | 0000000 | Copy restricted. Please purchase to unlock this data. | Copy restricted. Please purchase to unlock this data. | 0000000 |
This table provides a simplified preview of selected waste data points. To access the complete dataset with full disclosures and structure, create a free account to purchase the full dataset.
In 2024, Torrent Pharmaceuticals generated a total of 5,684 metric tonnes of waste.
Of this amount, 73.88% of Torrent Pharmaceuticals's total waste generated was recovered through methods such as recycling, reuse, or composting, while 26.12% was disposed of through landfilling, incineration, or combustion.
In 2024, Torrent Pharmaceuticals reported a total waste generation of 5,684 metric tonnes, of which 73.88% was recovered through recycling, reuse, or composting. This moderate level of recovery indicates that Torrent Pharmaceuticals is taking steps toward improving its waste diversion practices, though there is still room to enhance recycling and recovery efforts.
Since 2024, Torrent Pharmaceuticals's total waste generation has decreased by 14.2%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.
Over the same period, Torrent Pharmaceuticals's waste recovery rate increased by 1.28%.
In 2024, Torrent Pharmaceuticals generated a total of 5,684 metric tonnes of waste.
Of this amount, 57.61% of Torrent Pharmaceuticals's total waste generated of was classified as hazardous waste, characterized by properties such as toxicity, flammability, corrosiveness, or reactivity that may pose risks to human health, ecosystems, or the environment. 42.39% was identified as non-hazardous waste, generally considered less harmful and subject to lighter regulatory controls.
Since 2024, Torrent Pharmaceuticals's total waste generation has decreased by 14.2%, suggesting improvements in operational efficiency or the early results of waste minimization strategies.
Overall, Torrent Pharmaceuticals's waste and hazardousness trends are mixed or inconclusive. A more detailed review of its materials, industry standards, and operational changes would help clarify the net environmental impact of its waste strategy.
In 2024, Torrent Pharmaceuticals reported that 3,275 metric tonnes of its total waste output were classified as hazardous. This represents 57.61% of its overall waste generation.
The company treated this hazardous waste using a combination of methods. A majority (54.66%) was diverted from disposal through recovery-oriented treatments such as recycling or reuse. This suggests that Torrent Pharmaceuticals has established processes to reduce the environmental burden of its most harmful waste streams.